Edition:
United States

pSivida Corp (PSDV.OQ)

PSDV.OQ on NASDAQ Stock Exchange Global Market

1.93USD
12:02pm EST
Change (% chg)

$-0.01 (-0.52%)
Prev Close
$1.94
Open
$1.92
Day's High
$1.94
Day's Low
$1.91
Volume
2,707
Avg. Vol
33,600
52-wk High
$4.23
52-wk Low
$1.50

PSDV.OQ

Chart for PSDV.OQ

About

pSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $66.30
Shares Outstanding(Mil.): 34.18
Dividend: --
Yield (%): --

Financials

  PSDV.OQ Industry Sector
P/E (TTM): -- 45.90 30.76
EPS (TTM): -0.72 -- --
ROI: -106.72 -1.00 14.82
ROE: -142.92 -0.71 16.24

BRIEF-PSivida Corp posts Q1 loss per share $0.21

* Psivida Corp reports fiscal 2017 first quarter results and provides update on corporate objectives & milestone timeline

Nov 07 2016

BRIEF-Psivida board increases the number of directors of the board to 6

* On September 26, 2016, the board increased the number of directors of the board to six Source text - http://bit.ly/2cCOg5C Further company coverage:

Sep 28 2016

BRIEF-Psivida Corp reports Q4 loss per share $0.19

* Psivida Corp provides company update and reports fourth quarter and FY 2016 results

Sep 12 2016

BRIEF-Psivida announces 13 new patents issued or allowed

* Says an additional 108 applications are pending in U.S. and foreign jurisdictions Source text for Eikon: Further company coverage:

Aug 29 2016

Earnings vs. Estimates